This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arndts, D., Doevendans, J., Kirsten, R., Heintz, B.: New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man. Eur. J. Clin. Pharmacol. 24: 21–30 ( 1983.
Bailey, R. R.: Labetalol in the treatment of a patient with phaeochromocytoma: a case report. Br. J. Clin. Pharmacol. 8: 141–142 (1979).
Bean, B. L., Brown, J. J., Casals-Stenzel, J., Fraser, R., Lever, A. F., Millar, J. A., Morton, J. J., Petch, B., Riegger, A. J. G., Robertson, J. I. S., Tree, M.: The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Cir. Res. 44: 452–8 (1979).
Blakeley, A. G. H., Summers, R. J.: The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen. Br. J. Pharmacol. 59: 643–650 (1977).
Brecht, H. W., Banthien, F., Schoeppe, W.: Decrease in plasma noradrenaline levels following longterm treatment with prindolol in patients with essential hypertension. Klin. Wschr. 54: 1095–1105 (1976).
Carlsen, J. E., Trap-Jensen, J., Svendsen, T. L., Nielsen, P. E., Rasmussen, S., Christensen, N. J.: Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity. Postgrad. Med. J. 56: Suppl. 2, 43–47 (1980).
Carpenter, J. R.: Intrinsic activity of labetalol on guinea-pig isolated trachea. J. Pharm. Pharmacol. 33: 806–807 (1981).
Eliasson, K. et al.: Karolinska Sjukhuset Stockholm. Kurzberichte vom Schwedischen Ärztetag: Karolinska Sjukhuset Stockholm. Kurzberichte vom Schwedischen Ärztetag “Rikstämma” vom Dec. 1983. Beim Raynaud-Phänomen nach Betablockade auf Labetalol (TRAN-DATE) umsetzen. Arznei-Telegramm A 4330 E p. 5, January (1984).
Hansson, B.-G., Dymling, J.-F., Manhem, P., Hökfelt, B.: Long term treatment of moderate hypertension with the betas-receptor blocking agent metoprolol. Eur. J. Clin. Pharmacol. 11: 247–254 (1977).
Heitz, J., Haux, R., Gotzen, R.: Der Einfluß einer kombinierten a-und p-Rezeptoren-Blockade (Labetalol) auf die Plasmakatecholamine bei essentiellen Hypertonikern. Therapiewoche 30, No. 47: 7863–64 (1980).
Keusch, G., Weidmann, P., Ziegler, W. H., de Chatel, R., Reubi, F. C.: Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension Klin. Wochenschr. 58: 25–29 (1980).
Kirsten, R., Heintz, B., Böhmer, D., Nelson, K., Roth, S., Welzel, D.: Relationship of plasma catecholamines to blood pressure in hypertensive patients during (3-adrenoceptor blockade with and without intrinsic sympathomimetic activity. Br. J. Clin. Pharmacol. 13: 397–406 (1982).
L’Abbé, M., Tinel, J., Doumer, E.: Crises solaires et hypertension paroxystique en rapport avec une tumeur surrénale. Bull. Soc. Med. Hop. 46: 982–990 (1922).
Lechi, A., Picotti, G. B., Covi, G., Pomari, S., Pedrolli, E., Cesura, A. M., Danti, G., Mattioli, M.: Intravenous labetalol in severe hypertension — effects on blood pressure, plasma renin activity and catecholamines. Arzneim.-Forsch./Drug Res. 31 (I) Nr. 3 (1981).
de Leeuw, P. W., Falke, H. E., Kho, T. L., Vandogen, R., ‘Nester, A., Birkenhäger, W. H.: Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. Acta Med Scand 202: 389–392 (1977).
de Leeuw, P. W., Wester, A., Willemse, P. J., Birkenhäger, W. H.: Effects of prazosin on plasma noradrenaline and plasma renin concentrations in hypertensive subjects. J. Cardiovasc. Pharmacol$12., (Suppl. 3): 361–372 (1980).
Lijnen, P. J., Amery, A. K., Fagard, R. H., Reybrouck, T. M.: The effects of /3-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise. Br. J. Clin. Pharmacol. 7: 175–181 (1979).
Lijnen, P. J., Amery, A. K., Fagard, R. H., Reybrouck, T. M., Moerman, E. J., De Schaepdryver, A. F.: Effects of labetalol on plasma renin, aldosterone and catecholamines in hypertensive patients. J. Cardiovasc. Pharmacol. 1: 625–632 (1979).
Lin, M., McNay, J. L., Shepherd, A. M. M., Keeton, T. K.: The response of plasma catecholamines to intravenous labetalol: a comparison with sodium nitroprusside. Clin. Pharmacol. Ther. 34, 4: 466–473 (1983).
Marx, P. G., Reid, D. S.: Labetalol infusion in acute myocardial infarction with systemic hypertension. Br. J. clin. Pharmacol 8: 233–238 (1979).
Miano, L., Kolloch, R., de Quattro, V.: Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites. Clinica Chimica Acta 95: 211–217 (1979).
Michael, C. A.: Use of labetalol in the treatment of servere hypertension during pregnancy. Br. J. clin. Pharmacol. 8: 211–215 (1979).
Muiesan, T.,Discussion in: de Leeuw, P. W., Wester, A., Willemse, P. J., Birkenhäger, W. H. Effects of prazosin on plasma noradrenaline and plasma renin concentrations in hypertensive subjects. J. Cardiovasc. Pharmacol. 2, (Suppl. 3): 361–372 (1980).
Pisanti, N., Vacca, M., de Natale, G., Preziosi, P.: Labetalol disposition interferes with fluorometric dosage of catecholamines: in vitro and in vivo trials with enzymatic inhibitors. Pharmacol. Res. Commun. 12, No. 10: 937–44 (1980).
Preziosi, P., Pinsanti, N., Brevetti, G., Paudice, G., Moerman, E. J., de Schaepdryver, A. F.: Urinary catecholamines and labetalol. Arch. Intern. Pharmacodyn. 236, No. 2: 317–19 (1978).
Richards, D. A., Prichard, B. N. C.: Clinical pharamacology of labetalol. Br. J. clin. Pharmacol. 8: 89–93 (1979).
Strömbeck, J. P., Hedberg, T. P.: Tumor of the suprarenal medulla associated with paroxysmal hypertension. Report of case preoperatively diagnosed and cured by extirpation after capsular incision. Acta. Chir. Scand. 82: 177–189 (1939).
Summers, R. J., Tillman, J.: The effects of labetalol (AH 5158) on metabolism of 3H(—) noradrenaline released from the cat spleen by nerve stimulation. Biochem. Pharmacol. 26: 2137–2143 (1977).
Trap-Jensen, J., Carlsen, J., Hartling, O. J., et al.: Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline. Br. J. Clin. Pharmacol. 13/Suppl. 2: 391–395 (1982).
Uslar, A., Sinn, M., Schiffter, R.: Tremorbehandlung mit dem Betarezeptorenblocker Propranolol. Therapiewoche 27: 490 (1977).
Vlachakis, N. D., Velasquez, M., Barr, J., Alexander, N., Maronde, R. F.: Hemodynamic and catecholamine effects of labetalol in hypertensive patients. Clin. Res. 27, No. 2: 546A (1979).
Watson, R. D. S., Eriksson, B.-M., Hamilton, C. A., Reid, J. L., Stallard, T. J., Littler, W. A.: Effects of chronic beta-adrenoceptor antagonism on plasma catecholamines and blood pressure in hypertension. J. Cardiovasc. Pharmacol. 2: 725–738 (1980).
Weidmann, P., de Chatel, R., Ziegler, W. H., Flammer, J., Reubi, F.: Alpha and beta adrenergic blockade with orally administered labetalol in hypertension — Studies on blood volume, plasma renin and aldosterone and catecholamine excretion. The Am. J. Cardiol. Vol. 41: 570–576 (1978).
Wilcox, C. S., Lewis, P. S., Peart, W. S., Sever, P. S., Osikowska, B. A., Suddle, S. A. J., Bluhm, M. M., Veall, N., Lancaster, R.: Renal function, body fluid volumes, renin, aldosterone and noradrenaline during treatment of hypertension with pindolol. J. of Cardiovasc. Pharmac. 3: 598–611 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Fachmedien Wiesbaden
About this chapter
Cite this chapter
Kirsten, R., Nelson, K., Böhmer, D. (1984). The Response of Plasma Catecholamines to Receptor Antagonists. In: Rietbrock, N., Woodcock, B.G. (eds) Balanced Alpha/Beta Blockade of Adrenoceptors / Balancierte Blockade von Alpha- und Beta-Adrenozeptoren. Methods in Clinical Pharmacology. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-20205-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-663-20205-9_4
Publisher Name: Vieweg+Teubner Verlag, Wiesbaden
Print ISBN: 978-3-528-07922-2
Online ISBN: 978-3-663-20205-9
eBook Packages: Springer Book Archive